United States - English - NLM (National Library of Medicine)

carolina cannabis creations, l.l.c - arnica montana 5.6%............topical analgesic, menthol 11.3%...............topcial analgesic, cannabidiol 1.5%.........anti-inflammatory, delta 9 thc acid 2.9%.......anti-inflammatory, magnesium (dead sea salt) 9.7%...........topical analgesic, arnica montana 5.6%............topical analgesic, menthol 11.3%...............topcial analgesic, cannabidiol 1.5%.........anti-inflammatory, delta 9 thc acid 2.9%.......anti-inflammatory, magnesium (dead sea salt) 9.7%...........topical analgesic - temporary relief of aches and pains associated with arthritis, backache, muscle strains, sprains, joint pain

Australia - English - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 10 mg/ml; tetrahydrocannabinol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range as medicinal cannabis products may have a role in medical conditions including: ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia

Australia - English - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 20 mg/ml; tetrahydrocannabinol, quantity: 1 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range including 10:10 lgp classic, and 20:5 lgp classic as medicinal cannabis products, may have a role in medical conditions including:behavioural issues associated with autism, ? intractable epileptic seizures in adults and children, ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia

Australia - English - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 50 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - 1intractable chronic pain insufficiently responsive to other analgesics 2. pain associated with spasticity in multiple sclerosis (ms) 3. pain associated with cancer in palliative care 4. cancer treatment-induced nausea and vomiting 5. appetite loss 6. insomnia 7. post-traumatic stress disorder (ptsd) 8. cachexia 9. anxiety 10. refractory epilepsy

United States - English - NLM (National Library of Medicine)

strong current enterprises limited - camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), levomenthol (unii: bz1r15mtk7) (levomenthol - unii:bz1r15mtk7), cannabidiol (unii: 19gbj60sn5) (cannabidiol - unii:19gbj60sn5) - stop using this product and consult a doctor if:condition worsens allergic reaction like rash, itching and other skin irritation developed keep out of reach of children if ingested, seek medical/poison control attention immediately

Australia - English - Department of Health (Therapeutic Goods Administration)

althea company pty ltd - cannabidiol, quantity: 0 mg/ml; tetrahydrocannabinol, quantity: 20 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

althea company pty ltd - cannabidiol, quantity: 12.5 mg/ml; tetrahydrocannabinol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

althea company pty ltd - cannabidiol, quantity: 25 mg/ml; tetrahydrocannabinol, quantity: 0 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

epsilon pharma pty ltd - cannabidiol, quantity: 25 mg/ml - oral liquid - excipient ingredients: ascorbyl palmitate - insomnia (particularly in improving sleep quality) anxiety disorder chronic inflammatory pain depression

Australia - English - Department of Health (Therapeutic Goods Administration)

althea company pty ltd - cannabidiol, quantity: 12 mg/ml; tetrahydrocannabinol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides